UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 84

Sortiert nach

The 14 C, 13 C, and 15 N syntheses of a potent VEGFR‐2 kinase inhibitor, Brivanib, and its prodrug, Brivanib Alaninate

Journal of labelled compounds & radiopharmaceuticals, 2011-05, Vol.54 (6), p.324-331

2011

Link zum Volltext

Verfügbarkeit prüfen

The 14C, 13C, and 15N syntheses of a potent VEGFR-2 kinase inhibitor, Brivanib, and its prodrug, Brivanib Alaninate

Journal of labelled compounds & radiopharmaceuticals, 2011-05, Vol.54 (6), p.324-331

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2479: Preclinical assessment of imaging agents for identification of fucosyl-GM1 expression in vivo

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2479-2479

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 871: [18F]BMS-986192 as a novel PET imaging agent for assessment of PD-L1 expression in vivo

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.871-871

2017

Link zum Volltext

Verfügbarkeit prüfen

An alternative and robust synthesis of [13C4]Baraclude® (entecavir)

Journal of labelled compounds & radiopharmaceuticals, 2013-10, Vol.56 (12), p.632-636

2013

Link zum Volltext

Verfügbarkeit prüfen

Biotransformation of [14C]dasatinib: in vitro studies in rat, monkey, and human and disposition after administration to rats and monkeys

Drug metabolism and disposition, 2008-07, Vol.36 (7), p.1341

2008

Link zum Volltext

Verfügbarkeit prüfen

Biotransformation Profiling of [14C]Ixabepilone in Human Plasma, Urine and Feces Samples Using Accelerator Mass Spectrometry (AMS)

DRUG METABOLISM AND PHARMACOKINETICS, 2009-01, Vol.24 (6), p.511-522

2009

Link zum Volltext

Verfügbarkeit prüfen

Carbon-14 labeled methyl 2-chloro-2-oxoacetate: a convenient carbon-14 labeled oxalyl chloride equivalent

Journal of labelled compounds & radiopharmaceuticals, 2009-11, Vol.52 (13), p.549-552

2009

Link zum Volltext

Verfügbarkeit prüfen

Carbon-14 labeling of Saxagliptin (BMS-477118)

Journal of labelled compounds & radiopharmaceuticals, 2007-11, Vol.50 (13), p.1224-1229

2007

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the in vitro and in vivo metabolism and disposition and cytochrome P450 inhibition/induction profile of saxagliptin in human

Drug metabolism and disposition, 2012-07, Vol.40 (7), p.1345

2012

Link zum Volltext

Verfügbarkeit prüfen

Chemoselective Methionine Bioconjugation: Site-Selective Fluorine-18 Labeling of Proteins and Peptides

Bioconjugate chemistry, 2020-08, Vol.31 (8), p.1908-1916

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparative biotransformation of radiolabeled [(14)C]omapatrilat and stable-labeled [(13)C(2)]omapatrilat after oral administration to rats, dogs, and humans

Drug metabolism and disposition, 2003-01, Vol.31 (1), p.67

2003

Link zum Volltext

Verfügbarkeit prüfen

Cyclohexyl(2-methylenecyclopropyl)carbinyl carbocationic rearrangements

Journal of organic chemistry, 1993-02, Vol.58 (4), p.981-984

1993

Link zum Volltext

Verfügbarkeit prüfen

Development, Characterization, and Radiation Dosimetry Studies of 18 F-BMS-986229, a 18 F-Labeled PD-L1 Macrocyclic Peptide PET Tracer

Molecular imaging and biology, 2024-04, Vol.26 (2), p.301

2024

Link zum Volltext

Verfügbarkeit prüfen

Development, Characterization, and Radiation Dosimetry Studies of 18F-BMS-986229, a 18F-Labeled PD-L1 Macrocyclic Peptide PET Tracer

Molecular imaging and biology, 2024-04, Vol.26 (2), p.301-309

2024

Link zum Volltext

Verfügbarkeit prüfen

Direct Carbon Isotope Exchange through Decarboxylative Carboxylation

Journal of the American Chemical Society, 2019-01, Vol.141 (2), p.774-779

2019

Link zum Volltext

Verfügbarkeit prüfen

The discovery and evaluation of [18F]BMS-986229, a novel macrocyclic peptide PET radioligand for the measurement of PD-L1 expression and in-vivo PD-L1 target engagement

European journal of nuclear medicine and molecular imaging, 2024-03, Vol.51 (4), p.978-990

2024

Link zum Volltext

Verfügbarkeit prüfen

Distinguishing a phosphate ester prodrug from its isobaric sulfate metabolite by mass spectrometry without the metabolite standard

Rapid communications in mass spectrometry, 2009-10, Vol.23 (19), p.3107-3113

2009

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the Lysophosphatidic Acid Receptor Type 1 Radioligand 11 C-BMT-136088 for Lung Imaging in Rhesus Monkeys

Journal of Nuclear Medicine, 2018-02, Vol.59 (2), p.327-333

2018

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the Lysophosphatidic Acid Receptor Type 1 Radioligand 11C-BMT-136088 for Lung Imaging in Rhesus Monkeys

The Journal of nuclear medicine (1978), 2018-02, Vol.59 (2), p.327-333

2018

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the Lysophosphatidic Acid Receptor Type 1 Radioligand ^sup 11^C-BMT-136088 for Lung Imaging in Rhesus Monkeys

The Journal of nuclear medicine (1978), 2018-02, Vol.59 (2), p.327

2018

Link zum Volltext

Verfügbarkeit prüfen

A facile and efficient synthesis of d3-labelled Reyataz

Journal of labelled compounds & radiopharmaceuticals, 2005-12, Vol.48 (14), p.1041-1047

2005

Link zum Volltext

Verfügbarkeit prüfen

An improved synthesis of [2-14C]2, 5-dichloropyrimidine

Journal of labelled compounds & radiopharmaceuticals, 2012-06, Vol.55 (8), p.300-302

2012

Link zum Volltext

Verfügbarkeit prüfen

LC-MS/MS bioanalysis of plasma 1, 14-tetradecanedioic acid and 1, 16-hexadecanedioic acid as candidate biomarkers for organic anion-transporting polypeptide mediated drug-drug interactions

Bioanalysis, 2018-09, Vol.10 (18), p.1473-1485

2018

Link zum Volltext

Verfügbarkeit prüfen

Mechanistic Studies on a P450-Mediated Rearrangement of BMS-690514: Conversion of a Pyrrolotriazine to a Hydroxypyridotriazine

Chemical research in toxicology, 2011-01, Vol.24 (1), p.125-134

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(84)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(43)
Chemistry
(40)
Physical Sciences
(40)
Pharmacology & Pharmacy
(36)
Biochemical Research Methods
(30)
Biochemistry & Molecular Biology
(30)
Chemistry, Analytical
(29)
Chemistry, Medicinal
(27)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Pharmacology. Drug Treatments
(21)
Humans
(20)
Contrast Media. Radiopharmaceuticals
(14)
Animals
(10)
Carbon Radioisotopes - Chemistry
(9)
Chemistry Techniques, Synthetic
(8)
Carbon-14
(7)
Carbon‐14
(7)
Chemistry, Multidisciplinary
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The 14 C, 13 C, and 15 N syntheses of a potent VEGFR‐2 kinase inhibitor, Brivanib, and its prodrug, Brivanib Alaninate

The 14C, 13C, and 15N syntheses of a potent VEGFR-2 kinase inhibitor, Brivanib, and its prodrug, Brivanib Alaninate

Abstract 2479: Preclinical assessment of imaging agents for identification of fucosyl-GM1 expression in vivo

Abstract 871: [18F]BMS-986192 as a novel PET imaging agent for assessment of PD-L1 expression in vivo

An alternative and robust synthesis of [13C4]Baraclude® (entecavir)

Biotransformation of [14C]dasatinib: in vitro studies in rat, monkey, and human and disposition after administration to rats and monkeys

Biotransformation Profiling of [14C]Ixabepilone in Human Plasma, Urine and Feces Samples Using Accelerator Mass Spectrometry (AMS)

Carbon-14 labeled methyl 2-chloro-2-oxoacetate: a convenient carbon-14 labeled oxalyl chloride equivalent

Carbon-14 labeling of Saxagliptin (BMS-477118)

Characterization of the in vitro and in vivo metabolism and disposition and cytochrome P450 inhibition/induction profile of saxagliptin in human

Chemoselective Methionine Bioconjugation: Site-Selective Fluorine-18 Labeling of Proteins and Peptides

Comparative biotransformation of radiolabeled [(14)C]omapatrilat and stable-labeled [(13)C(2)]omapatrilat after oral administration to rats, dogs, and humans

Cyclohexyl(2-methylenecyclopropyl)carbinyl carbocationic rearrangements

Development, Characterization, and Radiation Dosimetry Studies of 18 F-BMS-986229, a 18 F-Labeled PD-L1 Macrocyclic Peptide PET Tracer

Development, Characterization, and Radiation Dosimetry Studies of 18F-BMS-986229, a 18F-Labeled PD-L1 Macrocyclic Peptide PET Tracer

Direct Carbon Isotope Exchange through Decarboxylative Carboxylation

The discovery and evaluation of [18F]BMS-986229, a novel macrocyclic peptide PET radioligand for the measurement of PD-L1 expression and in-vivo PD-L1 target engagement

Distinguishing a phosphate ester prodrug from its isobaric sulfate metabolite by mass spectrometry without the metabolite standard

Evaluation of the Lysophosphatidic Acid Receptor Type 1 Radioligand 11 C-BMT-136088 for Lung Imaging in Rhesus Monkeys

Evaluation of the Lysophosphatidic Acid Receptor Type 1 Radioligand 11C-BMT-136088 for Lung Imaging in Rhesus Monkeys

Evaluation of the Lysophosphatidic Acid Receptor Type 1 Radioligand ^sup 11^C-BMT-136088 for Lung Imaging in Rhesus Monkeys

A facile and efficient synthesis of d3-labelled Reyataz

An improved synthesis of [2-14C]2, 5-dichloropyrimidine

LC-MS/MS bioanalysis of plasma 1, 14-tetradecanedioic acid and 1, 16-hexadecanedioic acid as candidate biomarkers for organic anion-transporting polypeptide mediated drug-drug interactions

Mechanistic Studies on a P450-Mediated Rearrangement of BMS-690514: Conversion of a Pyrrolotriazine to a Hydroxypyridotriazine

Suchergebnisse filtern